The USPTO ruling “no interference in fact” in the CRISPR patents dispute, the unveiling of a new non-profit devoted to increasing awareness of IP rights, Alibaba accusing agencies of filing false complaints, IBM’s Manny Schecter calling for Congress to act on Section 101, and new patent case rules in the Northern District of California were in the intellectual property news in the past week
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
The government’s keenly awaited view on AI and copyright has positive themes but leaves rights owners wanting, says Rebecca Newman at Addleshaw Goddard
While IP Australia’s updated manual could be favourable to computer-implemented inventions, stakeholders would like to see whether a consistent and reliable standard is followed during actual examination